CONCORD BIOTECH LIMITEDCONCORDBIO
Stay updated on CONCORD BIOTECH LIMITED (CONCORDBIO), a Healthcare name listed on the NSE. This page aggregates market headlines and company-specific news for CONCORDBIO from trusted financial publishers, refreshed throughout the trading day.
There are currently 5 headlines in the feed window. Each item links to the original source so you can read the full story. Headlines are sorted with the newest coverage first; timestamps show how recently each publisher filed the story.
For live price, chart, market depth and option chain data, return to the CONCORDBIO overview page. Combining news flow with price action on tick2trade helps you judge whether a headline is already reflected in CONCORDBIO's quote or may still be working through the market.
- 01↗Strong Q1FY27 Financial Results and Growth Strategies AnnouncedBSE·7d·01 Aug 2026, 06:52 pm
- 02↗Concord Biotech Q1 profit jumps 33% as sales and margins improveCNBC·8d·31 Jul 2026, 08:35 pm
- 03↗Board Approves Q1 Financial Results for 2026BSE·8d·31 Jul 2026, 06:14 pm
- 04↗Concord Biotech Acquires Stake in Renewable Power Firm FSGENSE·49d·20 Jun 2026, 06:37 pm
- 05↗Concord Biotech shares gain 5% after bagging USFDA approval for $500 million drugCNBC·60d·10 Jun 2026, 11:33 am
Frequently asked questions
- How often is CONCORDBIO news updated?
- Headlines on this page refresh throughout the trading day as publishers file new stories mentioning CONCORD BIOTECH LIMITED. Older items remain visible until they roll out of the active feed window.
- Where does tick2trade source CONCORDBIO headlines?
- Stories are aggregated from established financial publishers. Each headline links to the original article so you can verify the source, timestamp and full context before acting on the news.
- How do I see live price data for CONCORDBIO?
- Open the CONCORDBIO overview page on NSE for live LTP, intraday range, chart, depth and derivatives panels. The news page focuses on headlines; the overview page focuses on market data.